Allworth Financial’s Neuronetics STIM Stock Holding History

Allworth Financial’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220	Buy	169 +146	+635%	+$212	﹤0.01%	4946
2026 Q1	$34	Buy	+23	New	+$36	﹤0.01%	5101

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allworth Financial's STIM Position: Q2 2026 in Review

Allworth Financial increased its Neuronetics (STIM) stake by 635% in Q2 2026, buying an estimated $212 and bringing the position to 169 shares worth $220. The position accounts for ﹤0.01% of the portfolio, ranked #4946.

Allworth Financial first reported a position in STIM in Q1 2026 and has held it in 2 quarters since. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

Allworth Financial held 169 shares of Neuronetics worth $220 as of Q2 2026.
Allworth Financial bought 146 Neuronetics shares in Q2 2026, an estimated $212.
Neuronetics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4946 holding.
Allworth Financial first reported a position in Neuronetics in Q1 2026 and has held it in 2 quarters since.
86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.